<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7636192" created="18/01/2007" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7636192</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Multiple <term id="A1" sem="Other">signals</term> are required for function of the <term id="T1" lex="human_granulocyte-macrophage_colony-stimulating_factor_gene_promoter" sem="DNA_domain_or_region"><term id="T2" lex="human_granulocyte-macrophage_colony-stimulating_factor" sem="Protein_molecule">human granulocyte-macrophage colony-stimulating factor</term> gene promoter</term> in <term id="T3" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="A1"/>
<clue>Multiple signals are <clueType>required</clueType> <linkTheme>for</linkTheme> function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.</clue>
</event>
<event KT="Other" id="E2">
<type class="Regulation"/>
<cause idref="T1"/>
<clue>Multiple signals are required for <clueType>function</clueType> <linkCause>of</linkCause> the human granulocyte-macrophage colony-stimulating factor gene promoter <clueLoc>in T cells</clueLoc>.</clue>
<comment>NO THEME</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T4" lex="human_granulocyte-macrophage_CSF_(GM-CSF)_gene" sem="DNA_domain_or_region"><term id="T5" lex="human_granulocyte-macrophage_CSF" sem="Protein_molecule">human granulocyte-macrophage CSF</term> (<term id="A2" sem="DNA_domain_or_region"><term id="T6" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term>) gene</term></term> is expressed in <term id="T7" lex="T_cell" sem="Cell_natural">T cells</term> in response to <term id="T8" lex="TCR_activation" sem="Other"><term id="T9" lex="TCR" sem="Protein_family_or_group">TCR</term> activation</term> that can be mimicked by treatment of the cells with <term id="T10" lex="PMA" sem="Organic_compound_other">PMA</term> and <term id="T11" lex="Ca2+_ionophore" sem="Organic_compound_other"><term id="T12" lex="Ca2+" sem="Element">Ca2+</term> ionophore</term>.</sentence>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="A2"/>
<clue>The human granulocyte-macrophage CSF (GM-CSF) gene is <clueType>expressed</clueType> <clueLoc>in T cells</clueLoc> in response to TCR activation that can be mimicked by treatment of the cells with PMA and Ca2+ ionophore.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="E5"/>
<clue>The human granulocyte-macrophage CSF (GM-CSF) gene is expressed in T cells <linkCause>in response to</linkCause> TCR activation that can be mimicked by treatment of the cells with PMA and Ca2+ ionophore.</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="T9"/>
<clue>The human granulocyte-macrophage CSF (GM-CSF) gene is expressed in T cells in response to TCR <clueType>activation</clueType> that can be mimicked by treatment of the cells with PMA and Ca2+ ionophore.</clue>
</event>
<event CL="L2" KT="Analysis" id="E6">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="E7"/>
<cause idref="E49"/>
<clue>The human granulocyte-macrophage CSF (GM-CSF) gene is expressed in T cells in response to TCR activation that <clueKT><clueCL>can</clueCL></clueKT> be mimicked <linkCause>by</linkCause> treatment of the cells with PMA and Ca2+ ionophore.</clue>
<comment>CAUTION, mimicked</comment></event>
<event KT="Method" id="E7">
<type class="Artificial_process"/>
<theme idref="T7"/>
<theme idref="T10"/>
<clue>The human granulocyte-macrophage CSF (GM-CSF) gene is expressed in T cells in response to TCR activation that can be mimicked by <clueType>treatment</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkTheme>with</linkTheme> PMA and Ca2+ ionophore.</clue>
</event>
<event KT="Method" id="E49">
<type class="Artificial_process"/>
<theme idref="T7"/>
<theme idref="T11"/>
<clue>The human granulocyte-macrophage CSF (GM-CSF) gene is expressed in T cells in response to TCR activation that can be mimicked by <clueType>treatment</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkTheme>with</linkTheme> PMA and Ca2+ ionophore.</clue>
</event>
<sentence id="S3">The gene contains a <term id="T13" lex="proximal_functional_promoter_region" sem="DNA_domain_or_region">proximal functional promoter region</term> (<term id="T14" lex="-620_to_+34" sem="DNA_domain_or_region">-620 to +34</term>), as well as a powerful <term id="A3" sem="DNA_domain_or_region"><term id="T15" lex="enhancer" sem="DNA_domain_or_region">enhancer</term> located 3 kb upstream</term>, both of which are involved in the response of the gene to <term id="T16" lex="TCR_activation" sem="Other"><term id="T17" lex="TCR" sem="Protein_family_or_group">TCR</term> activation</term>.</sentence>
<event KT="Fact" id="E8">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="T13"/>
<clue>The gene contains a proximal functional promoter region (-620 to +34), as well as a powerful enhancer located 3 kb upstream, both of which are <clueType>involved</clueType> <linkTheme>in</linkTheme> the response of the gene to TCR activation.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="A3"/>
<clue>The gene contains a proximal functional promoter region (-620 to +34), as well as a powerful enhancer located 3 kb upstream, both of which are <clueType>involved</clueType> <linkTheme>in</linkTheme> the response of the gene to TCR activation.</clue>
<comment>TPS: A3</comment></event>
<event KT="Other" id="E9">
<type class="Regulation"/>
<theme idref="A2"/>
<cause idref="E10"/>
<clue>The gene contains a proximal functional promoter region (-620 to +34), as well as a powerful enhancer located 3 kb upstream, both of which are involved in the <clueType>response</clueType> <linkTheme>of</linkTheme> <corefTheme>the gene</corefTheme> <linkCause>to</linkCause> TCR activation.</clue>
</event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="T17"/>
<clue>The gene contains a proximal functional promoter region (-620 to +34), as well as a powerful enhancer located 3 kb upstream, both of which are involved in the response of the gene to TCR <clueType>activation</clueType>.</clue>
</event>
<sentence id="S4">The <term id="T18" lex="proximal_promoter" sem="DNA_domain_or_region">proximal promoter</term> contains a region termed <term id="T19" lex="CLEO" sem="DNA_domain_or_region">CLEO</term> (<term id="T20" lex="-54_to_-31" sem="DNA_domain_or_region">-54 to -31</term>) that consists of a <term id="T21" lex="purine-rich_element" sem="DNA_domain_or_region"><term id="T22" lex="purine" sem="Nucleotide">purine</term>-rich element</term> abutting an <term id="T23" lex="activator_protein-1_(AP-1)-like_site" sem="DNA_domain_or_region"><term id="T24" lex="activator_protein-1" sem="Protein_molecule">activator protein-1</term> (<term id="T25" lex="AP-1" sem="Protein_molecule">AP-1</term>)-like site</term>, as well as an <term id="T26" lex="upstream_nuclear_factor-kappa_B_(NF-kappa_B)_site" sem="DNA_domain_or_region">upstream <term id="T27" lex="nuclear_factor-kappa_B" sem="Protein_molecule">nuclear factor-kappa B</term> (<term id="T28" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term>) site</term> (<term id="T29" lex="-85_to_-76" sem="DNA_domain_or_region">-85 to -76</term>) and a <term id="T30" lex="CK-1_element" sem="DNA_domain_or_region">CK-1 element</term> (<term id="T31" lex="-101_to_-92" sem="DNA_domain_or_region">-101 to -92</term>).</sentence>
<sentence id="S5">We show in this work that mutations in either the <term id="A4" sem="DNA_domain_or_region"><term id="T32" lex="purine-rich_region" sem="DNA_domain_or_region"><term id="T33" lex="purine" sem="Nucleotide">purine</term>-rich region</term> of the <term id="T34" lex="CLEO_element" sem="DNA_domain_or_region"><term id="T35" lex="CLEO" sem="DNA_domain_or_region">CLEO</term> element</term></term> or the <term id="T36" lex="NF-kappa_B_site" sem="DNA_domain_or_region"><term id="T37" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> site</term> result in reduced <term id="T38" lex="PMA" sem="Organic_compound_other">PMA</term>/<term id="T39" lex="Ca2+_activation" sem="Other"><term id="T40" lex="Ca2+" sem="Element">Ca2+</term> activation</term> of a <term id="T41" lex="620-bp_human_GM-CSF_promoter-_luciferase_reporter_construct" sem="DNA_molecule">620-bp human <term id="T42" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> promoter-<term id="T43" lex="luciferase" sem="Protein_molecule">luciferase</term> reporter construct</term> in <term id="T44" lex="Jurkat_T_cell" sem="Cell_cultured">Jurkat <term id="T45" lex="T_cell" sem="Cell_natural">T cells</term></term> by 65% and 50%, respectively.</sentence>
<event KT="Method" id="E11">
<type class="Mutagenesis"/>
<theme idref="A4"/>
<clue>We show in this work that <clueType>mutations</clueType> <linkTheme>in</linkTheme> either the purine-rich region of the CLEO element or the NF-kappa B site result in reduced PMA/Ca2+ activation of a 620-bp human GM-CSF promoter-luciferase reporter construct in Jurkat T cells by 65% and 50%, respectively.</clue>
<comment>TPS: A4; ARTIFICIAL</comment></event>
<event KT="Method" id="E17">
<type class="Mutagenesis"/>
<theme idref="T36"/>
<clue>We show in this work that <clueType>mutations</clueType> <linkTheme>in</linkTheme> either the purine-rich region of the CLEO element or the NF-kappa B site result in reduced PMA/Ca2+ activation of a 620-bp human GM-CSF promoter-luciferase reporter construct in Jurkat T cells by 65% and 50%, respectively.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Other" Manner="High" id="E13">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="E11"/>
<clue>We show in this work that mutations in either the purine-rich region of the CLEO element or the NF-kappa B site result in <clueType>reduced</clueType> PMA/Ca2+ activation of a 620-bp human GM-CSF promoter-luciferase reporter construct in Jurkat T cells <clueManner>by 65%</clueManner> and 50%, respectively.</clue>
</event>
<event KT="Other" Manner="High" id="E18">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="E17"/>
<clue>We show in this work that mutations in either the purine-rich region of the CLEO element or the NF-kappa B site result in <clueType>reduced</clueType> PMA/Ca2+ activation of a 620-bp human GM-CSF promoter-luciferase reporter construct in Jurkat T cells <clueManner>by</clueManner> 65% and <clueManner>50%</clueManner>, respectively.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="T41"/>
<cause idref="T38"/>
<clue>We show in this work that mutations in either the purine-rich region of the CLEO element or the NF-kappa B site result in reduced PMA/Ca2+ <clueType>activation</clueType> <linkTheme>of</linkTheme> a 620-bp human GM-CSF promoter-luciferase reporter construct <clueLoc>in Jurkat T cells</clueLoc> by 65% and 50%, respectively.</clue>
</event>
<sentence id="S6">The major <term id="T46" lex="inducible_protein_complex" sem="Protein_complex">inducible protein complex</term> that binds to the <term id="T47" lex="human_CLEO_(hCLEO)_element" sem="DNA_domain_or_region">human <term id="T48" lex="CLEO" sem="DNA_domain_or_region">CLEO</term> (<term id="T49" lex="hCLEO" sem="DNA_domain_or_region">hCLEO</term>) element</term> is an <term id="T50" lex="AP-1-like_complex" sem="Protein_complex"><term id="T51" lex="AP-1" sem="Protein_molecule">AP-1</term>-like complex</term> that is inducible by <term id="T52" lex="PMA" sem="Organic_compound_other">PMA</term> alone, but shows increased binding in response to <term id="T53" lex="PMA" sem="Organic_compound_other">PMA</term> together with <term id="T54" lex="Ca2+_ionophore" sem="Organic_compound_other"><term id="T55" lex="Ca2+" sem="Element">Ca2+</term> ionophore</term>.</sentence>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="T50"/>
<clue>The major <clueType>inducible</clueType> protein complex that binds to the human CLEO (hCLEO) element is an AP-1-like complex that is inducible by PMA alone, but shows increased binding in response to PMA together with Ca2+ ionophore.</clue>
</event>
<event KT="Fact" id="E16">
<type class="Binding"/>
<theme idref="T50"/>
<theme idref="T49"/>
<clue>The major inducible protein complex that <clueType>binds</clueType> <linkTheme>to</linkTheme> the human CLEO (hCLEO) element is an AP-1-like complex that is inducible by PMA alone, but shows increased binding in response to PMA together with Ca2+ ionophore.</clue>
</event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="T53"/>
<clue>The major inducible protein complex that binds to the human CLEO (hCLEO) element is an AP-1-like complex that is <clueType>inducible</clueType> <linkCause>by</linkCause> PMA alone, but shows increased binding in response to PMA together with Ca2+ ionophore.</clue>
</event>
<event KT="Analysis" id="E22">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="T54"/>
<clue>The major inducible protein complex that binds to the human CLEO (hCLEO) element is an AP-1-like complex that is inducible by PMA alone, but <clueKT>shows</clueKT> <clueType>increased</clueType> <corefTheme>binding in response to PMA</corefTheme> <linkCause>together with</linkCause> Ca2+ ionophore.</clue>
</event>
<sentence id="S7">Although the binding of this complex is not <term id="T56" lex="cyclosporin-sensitive" sem="Other"><term id="T57" lex="cyclosporin" sem="Organic_compound_other">cyclosporin</term>-sensitive</term>, <term id="T58" lex="promoter_induction" sem="Other">promoter induction</term> is inhibited by <term id="T59" lex="cyclosporin_treatment" sem="Other"><term id="T60" lex="cyclosporin" sem="Organic_compound_other">cyclosporin</term> treatment</term>.</sentence>
<event id="E23">
<type class="Binding"/>
<theme idref="T50"/>
<clue>Although the <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>this complex</corefTheme> is not cyclosporin-sensitive, promoter induction is inhibited by cyclosporin treatment.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E24">
<type class="Regulation"/>
<theme idref="E23"/>
<cause idref="T57"/>
<clue>Although the binding of this complex is <cluePolarity>not</cluePolarity> cyclosporin-<clueType>sensitive</clueType>, promoter induction is inhibited by cyclosporin treatment.</clue>
</event>
<event KT="Other" id="E25">
<type class="Positive_regulation"/>
<theme idref="T49"/>
<clue>Although the binding of this complex is not cyclosporin-sensitive, <corefTheme>promoter</corefTheme> <clueType>induction</clueType> is inhibited by cyclosporin treatment.</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="E25"/>
<cause idref="T60"/>
<clue>Although the binding of this complex is not cyclosporin-sensitive, promoter induction is <clueType>inhibited</clueType> <linkCause>by</linkCause> cyclosporin treatment.</clue>
</event>
<sentence id="S8">A second weak inducible <term id="A5" sem="Protein_complex">complex resembling</term> <term id="T61" lex="nuclear_factor_of_activated_T_cells" sem="Protein_family_or_group">nuclear factor of activated T cells</term> (<term id="A6" sem="Protein_complex"><term id="T62" lex="NF-AT" sem="Protein_family_or_group">NF-AT</term></term>) was also observed binding to the <term id="T63" lex="hCLEO_region" sem="DNA_domain_or_region"><term id="T64" lex="hCLEO" sem="DNA_domain_or_region">hCLEO</term> region</term>.</sentence>
<event Manner="Low" id="E28">
<type class="Positive_regulation"/>
<theme idref="A5" idref1="A6"/>
<clue>A second <clueManner>weak</clueManner> <clueType>inducible</clueType> complex resembling nuclear factor of activated T cells (NF-AT) was also <clueKT>observed</clueKT> binding to the hCLEO region.</clue>
</event>
<event id="E29">
<type class="Binding"/>
<theme idref="A5" idref1="A6"/>
<theme idref="T64"/>
<clue>A second weak inducible complex resembling nuclear factor of activated T cells (NF-AT) was also observed <clueType>binding</clueType> <linkTheme>to</linkTheme> the hCLEO region.</clue>
</event>
<sentence id="S9">By using <term id="T65" lex="recombinant_protein" sem="Protein_family_or_group">recombinant proteins</term>, we confirmed that <term id="T66" lex="AP-1" sem="Protein_molecule">AP-1</term>, <term id="T67" lex="NF-ATp" sem="Protein_molecule">NF-ATp</term>, and a higher order <term id="T68" lex="NF-ATp/AP-1_complex" sem="Protein_complex"><term id="A7" sem="Protein_complex"><term id="T69" lex="NF-ATp" sem="Protein_molecule">NF-ATp</term>/<term id="T70" lex="AP-1" sem="Protein_molecule">AP-1</term></term> complex</term> could all form with the <term id="T71" lex="hCLEO_element" sem="DNA_domain_or_region"><term id="T72" lex="hCLEO" sem="DNA_domain_or_region">hCLEO</term> element</term>, and we have also defined the <term id="A8" sem="DNA_domain_or_region">sequence</term> requirements for binding of each of these complexes.</sentence>
<event KT="Analysis" id="E30">
<type class="Binding"/>
<theme idref="T66"/>
<theme idref="T71"/>
<clue>By using recombinant proteins, we <clueKT>confirmed</clueKT> that AP-1, NF-ATp, and a higher order NF-ATp/AP-1 <clueType>complex</clueType> could all <clueType>form</clueType> <linkTheme>with</linkTheme> the hCLEO element, and we have also defined the sequence requirements for binding of each of these complexes.</clue>
</event>
<event KT="Analysis" id="E31">
<type class="Binding"/>
<theme idref="T67"/>
<theme idref="T71"/>
<clue>By using recombinant proteins, we <clueKT>confirmed</clueKT> that AP-1, NF-ATp, and a higher order NF-ATp/AP-1 <clueType>complex</clueType> could all <clueType>form</clueType> <linkTheme>with</linkTheme> the hCLEO element, and we have also defined the sequence requirements for binding of each of these complexes.</clue>
</event>
<event KT="Analysis" id="E32">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T71"/>
<clue>By using recombinant proteins, we <clueKT>confirmed</clueKT> that AP-1, NF-ATp, and a higher order NF-ATp/AP-1 <clueType>complex</clueType> could all <clueType>form</clueType> <linkTheme>with</linkTheme> the hCLEO element, and we have also defined the sequence requirements for binding of each of these complexes.</clue>
</event>
<event KT="Analysis" id="E34">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T71" idref1="A8"/>
<clue>By using recombinant proteins, we confirmed that AP-1, NF-ATp, and a higher order NF-ATp/AP-1 complex could all form with the hCLEO element, and we have also <clueKT>defined</clueKT> the sequence <clueType>requirements</clueType> <linkTheme>for</linkTheme> <corefTheme>binding of each of these complexes</corefTheme>.</clue>
</event>
<event KT="Analysis" id="E35">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<cause idref="T71" idref1="A8"/>
<clue>By using recombinant proteins, we confirmed that AP-1, NF-ATp, and a higher order NF-ATp/AP-1 complex could all form with the hCLEO element, and we have also <clueKT>defined</clueKT> the sequence <clueType>requirements</clueType> <linkTheme>for</linkTheme> <corefTheme>binding of each of these complexes</corefTheme>.</clue>
</event>
<event KT="Analysis" id="E36">
<type class="Positive_regulation"/>
<theme idref="E32"/>
<cause idref="T71" idref1="A8"/>
<clue>By using recombinant proteins, we confirmed that AP-1, NF-ATp, and a higher order NF-ATp/AP-1 complex could all form with the hCLEO element, and we have also <clueKT>defined</clueKT> the sequence <clueType>requirements</clueType> <linkTheme>for</linkTheme> <corefTheme>binding of each of these complexes</corefTheme>.</clue>
</event>
<sentence id="S10">We found that expression of a constitutively <term id="A20" sem="Protein_molecule">active form of <term id="T73" lex="calcineurin" sem="Protein_molecule">calcineurin</term></term> could substitute for <term id="T74" lex="Ca2+_ionophore" sem="Organic_compound_other"><term id="T75" lex="Ca2+" sem="Element">Ca2+</term> ionophore</term> and synergize with <term id="T76" lex="PMA" sem="Organic_compound_other">PMA</term> to activate the <term id="T77" lex="GM-CSF_promoter" sem="DNA_domain_or_region"><term id="T78" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> promoter</term>, and conversely that <term id="T79" lex="mutant-activated_Ras" sem="Protein_molecule">mutant-activated Ras</term> could substitute for <term id="T80" lex="PMA" sem="Organic_compound_other">PMA</term> and cooperate with <term id="T81" lex="Ca2+_ionophore" sem="Organic_compound_other"><term id="T82" lex="Ca2+" sem="Element">Ca2+</term> ionophore</term>.</sentence>
<event id="E33">
<type class="Gene_expression"/>
<theme idref="T73"/>
<clue>We found that <clueType>expression</clueType> <linkTheme>of</linkTheme> a constitutively active form of calcineurin could substitute for Ca2+ ionophore and synergize with PMA to activate the GM-CSF promoter, and conversely that mutant-activated Ras could substitute for PMA and cooperate with Ca2+ ionophore.</clue>
</event>
<event id="E37">
<type class="Positive_regulation"/>
<theme idref="T73"/>
<clue>We found that expression of a constitutively <clueType>active form</clueType> <linkTheme>of</linkTheme> calcineurin could substitute for Ca2+ ionophore and synergize with PMA to activate the GM-CSF promoter, and conversely that mutant-activated Ras could substitute for PMA and cooperate with Ca2+ ionophore.</clue>
</event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="T77"/>
<cause idref="A20"/>
<cause idref="T76"/>
<clue>We <clueKT>found</clueKT> that expression of a constitutively active form of calcineurin could substitute for Ca2+ ionophore and <clueType>synergize</clueType> <linkCause>with</linkCause> PMA to <clueType>activate</clueType> the GM-CSF promoter, and conversely that mutant-activated Ras could substitute for PMA and cooperate with Ca2+ ionophore.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="T77"/>
<cause idref="T79"/>
<cause idref="T81"/>
<clue>We <clueKT>found</clueKT> that expression of a constitutively active form of calcineurin could substitute for Ca2+ ionophore and synergize with PMA to activate the GM-CSF promoter, and conversely that mutant-activated Ras could substitute for PMA and <clueType>cooperate</clueType> <linkCause>with</linkCause> Ca2+ ionophore.</clue>
<comment>CAUTION, c/o E38, synergize to activate</comment></event>
<sentence id="S11">Co-expression of <term id="T83" lex="Ras" sem="Protein_molecule">Ras</term> and <term id="T84" lex="calcineurin" sem="Protein_molecule">calcineurin</term>, however, did not activate the <term id="T85" lex="GM-CSF_promoter" sem="DNA_domain_or_region"><term id="T86" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> promoter</term>, but required the additional expression of <term id="T87" lex="NF-kappa_B_p65" sem="Protein_molecule"><term id="T88" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> p65</term>.</sentence>
<event id="E40">
<type class="Gene_expression"/>
<theme idref="T83"/>
<clue>Co-<clueType>expression</clueType> <linkTheme>of</linkTheme> Ras and calcineurin, however, did not activate the GM-CSF promoter, but required the additional expression of NF-kappa B p65.</clue>
</event>
<event id="E42">
<type class="Gene_expression"/>
<theme idref="T84"/>
<clue>Co-<clueType>expression</clueType> <linkTheme>of</linkTheme> Ras and calcineurin, however, did not activate the GM-CSF promoter, but required the additional expression of NF-kappa B p65.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E43">
<type class="Positive_regulation"/>
<theme idref="T85"/>
<cause idref="E40"/>
<cause idref="E41"/>
<clue>Co-expression of Ras and calcineurin, however, did <cluePolarity>not</cluePolarity> <clueType>activate</clueType> the GM-CSF promoter, but required the additional expression of NF-kappa B p65.</clue>
</event>
<event id="E44">
<type class="Positive_regulation"/>
<theme idref="T85"/>
<cause idref="E40"/>
<cause idref="E41"/>
<cause idref="E45"/>
<clue>Co-expression of Ras and calcineurin, however, did not activate the GM-CSF promoter, but <clueType>required</clueType> the <linkCause>additional</linkCause> expression of NF-kappa B p65.</clue>
</event>
<event id="E45">
<type class="Gene_expression"/>
<theme idref="T87"/>
<clue>Co-expression of Ras and calcineurin, however, did not activate the GM-CSF promoter, but required the additional <clueType>expression</clueType> <linkTheme>of</linkTheme> NF-kappa B p65.</clue>
</event>
<sentence id="S12">These results imply that at least three <term id="A9" sem="Other">signals</term> are required to activate the <term id="T89" lex="GM-CSF_proximal_promoter" sem="DNA_domain_or_region"><term id="T90" lex="GM-CSF" sem="Protein_molecule">GM-CSF</term> <term id="T91" lex="proximal_promoter" sem="DNA_domain_or_region">proximal promoter</term></term>, and that the signals impinge on distinct <term id="T92" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> that bind to the <term id="T94" lex="hCLEO" sem="DNA_domain_or_region"><term id="T95" lex="hCLEO_region" sem="DNA_domain_or_region">hCLEO</term></term> and <term id="T96" lex="NF-kappa_B_region" sem="DNA_domain_or_region"><term id="T97" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> regions</term> of the <term id="T98" lex="promoter" sem="DNA_domain_or_region">promoter</term>.</sentence>
<event CL="L2" KT="Analysis" id="E41">
<type class="Positive_regulation"/>
<theme idref="T89"/>
<cause idref="A9"/>
<clue>These results <clueKT><clueCL>imply</clueCL></clueKT> that at least three signals are <clueType>required to activate</clueType> the GM-CSF proximal promoter, and that the signals impinge on distinct transcription factors that bind to the hCLEO and NF-kappa B regions of the promoter.</clue>
</event>
<event CL="L2" KT="Analysis" id="E46">
<type class="Regulation"/>
<theme idref="T92"/>
<cause idref="A9"/>
<clue>These results <clueKT><clueCL>imply</clueCL></clueKT> that at least three signals are required to activate the GM-CSF proximal promoter, and that <corefCause>the signals</corefCause> <clueType>impinge</clueType> <linkTheme>on</linkTheme> distinct transcription factors that bind to the hCLEO and NF-kappa B regions of the promoter.</clue>
</event>
<event KT="Other" id="E47">
<type class="Binding"/>
<theme idref="T92"/>
<theme idref="T94"/>
<clue>These results imply that at least three signals are required to activate the GM-CSF proximal promoter, and that the signals impinge on distinct transcription factors that <clueType>bind</clueType> <linkTheme>to</linkTheme> the hCLEO and NF-kappa B regions of the promoter.</clue>
<comment>NER: T93 del &quot;hCLEO and NF-kappa B regions of the promoter&quot;</comment></event>
<event KT="Other" id="E48">
<type class="Binding"/>
<theme idref="T92"/>
<theme idref="T96"/>
<clue>These results imply that at least three signals are required to activate the GM-CSF proximal promoter, and that the signals impinge on distinct transcription factors that <clueType>bind</clueType> <linkTheme>to</linkTheme> the hCLEO and NF-kappa B regions of the promoter.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
